Modification of the Antitumor Action of Cytostatic Drugs Using a Copolymer of N-Vinylpyrrolidone and 2-Methyl-5-Vinylpyridine
- Authors: Panov A.V.1,2, Kochkina Y.V.1,2, Yartsev E.I.2, Eremin D.V.1,2, Yakovleva T.A.2, Kedik S.A.1,2
- 
							Affiliations: 
							- Moscow Technology University (MITKhT)
- Institute of Pharmaceutical Technologies
 
- Issue: Vol 51, No 7 (2017)
- Pages: 523-527
- Section: Molecular Biological Problems of Drug Design and Mechanism of Drug Action
- URL: https://ogarev-online.ru/0091-150X/article/view/244693
- DOI: https://doi.org/10.1007/s11094-017-1647-7
- ID: 244693
Cite item
Abstract
Simultaneous administration of a copolymer of N-vinylpyrrolidone and 2-methyl-5-vinylpyridine and cytostatic agents to mice with a variety of implanted tumors was found to increase treatment efficacy, promoting increases in survival time. This effect is of interest for further studies of the possible use of copolymer as an immunomodulator in chemotherapy.
About the authors
A. V. Panov
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
Yu. V. Kochkina
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
							Author for correspondence.
							Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
E. I. Yartsev
Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							21/32 Skolkovskoe Chaussee, Moscow, 121353						
D. V. Eremin
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
T. A. Yakovleva
Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							21/32 Skolkovskoe Chaussee, Moscow, 121353						
S. A. Kedik
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Russian Federation, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					